• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

帕金森病患者中脑多巴胺神经元移植物 12-22 岁时的退变迹象。

Signs of degeneration in 12-22-year old grafts of mesencephalic dopamine neurons in patients with Parkinson's disease.

机构信息

Wallenberg Neuroscience Center, Lund.

出版信息

J Parkinsons Dis. 2011;1(1):83-92. doi: 10.3233/JPD-2011-11004.

DOI:10.3233/JPD-2011-11004
PMID:23939259
Abstract

We demonstrate that grafted human fetal mesencephalic neurons can survive and extend axons for 22 years in the brain of a patient with Parkinson's disease (PD). In this patient, the overall survival and fiber outgrowth of the grafts were, however, relatively poor, which is consistent with the lack of significant clinical graft-induced benefit. We have compared the morphology of neurons in the 22-year old grafts with those in two younger grafts (16- and 12-year old), which were sequentially implanted in another PD patient. In the case with the 22-year-old transplant, a high proportion (up to 38%) of the grafted dopaminergic (pigment-granule containing) neurons do not express tyrosine hydroxylase and dopamine transporter and their perikarya appear atrophic. The proportion of pigmented neurons not expressing these markers is lower in the 12-16 year old grafts. Furthermore, in the 22-year-old graft, 49% of the pigmented neurons display α-synuclein immunoreactivity in the cell body and 1.2% of them contain Lewy bodies. In conclusion, our results show that grafted dopaminergic neurons can survive for more than two decades. However, over time an increasing proportion of grafted neurons exhibit signs of degeneration.

摘要

我们证明,在帕金森病(PD)患者的大脑中,移植的人胎脑内神经元可以存活 22 年并延伸轴突。然而,在该患者中,移植物的整体存活率和纤维生长相对较差,这与缺乏明显的临床移植物诱导益处一致。我们比较了 22 年移植物中的神经元形态与另外两个年轻移植物(16 岁和 12 岁)中的神经元形态,这两个移植物依次植入另一名 PD 患者体内。在 22 岁的移植患者中,高达 38%的移植多巴胺能(含色素颗粒)神经元不表达酪氨酸羟化酶和多巴胺转运体,其胞体呈现萎缩。在 12-16 岁的移植物中,不表达这些标志物的色素神经元比例较低。此外,在 22 岁的移植物中,49%的色素神经元在细胞体中显示α-突触核蛋白免疫反应性,其中 1.2%含有路易体。总之,我们的结果表明,移植的多巴胺能神经元可以存活超过 20 年。然而,随着时间的推移,越来越多的移植神经元出现退化迹象。

相似文献

1
Signs of degeneration in 12-22-year old grafts of mesencephalic dopamine neurons in patients with Parkinson's disease.帕金森病患者中脑多巴胺神经元移植物 12-22 岁时的退变迹象。
J Parkinsons Dis. 2011;1(1):83-92. doi: 10.3233/JPD-2011-11004.
2
Anatomical and functional reconstruction of the nigrostriatal pathway by intranigral transplants.通过黑质内移植实现黑质纹状体通路的解剖学和功能重建。
Neurobiol Dis. 2009 Sep;35(3):477-88. doi: 10.1016/j.nbd.2009.07.003. Epub 2009 Jul 17.
3
Evidence for target-specific nerve fiber outgrowth from subpopulations of grafted dopaminergic neurons: a retrograde tracing study using in oculo and intracranial grafting.移植的多巴胺能神经元亚群中靶标特异性神经纤维生长的证据:一项使用眼内和颅内移植的逆行追踪研究。
Exp Neurol. 2001 Jun;169(2):329-39. doi: 10.1006/exnr.2001.7658.
4
Characterization of Lewy body pathology in 12- and 16-year-old intrastriatal mesencephalic grafts surviving in a patient with Parkinson's disease.12 岁和 16 岁纹状体间位脑桥内移植物中路易体病理学的特征,这些移植物在一名帕金森病患者中存活。
Mov Disord. 2010 Jun 15;25(8):1091-6. doi: 10.1002/mds.23012.
5
Fetal nigral grafts survive and mediate clinical benefit in a patient with Parkinson's disease.胎儿黑质移植在一名帕金森病患者体内存活并产生临床益处。
Mov Disord. 1998 May;13(3):383-93. doi: 10.1002/mds.870130303.
6
The time course of loss of dopaminergic neurons and the gliotic reaction surrounding grafts of embryonic mesencephalon to the striatum.多巴胺能神经元丧失的时间进程以及胚胎中脑移植到纹状体后移植物周围的胶质反应。
Exp Neurol. 1996 Sep;141(1):79-93. doi: 10.1006/exnr.1996.0141.
7
Neuropathology in transplants in Parkinson's disease: implications for disease pathogenesis and the future of cell therapy.移植治疗帕金森病的神经病理学:对疾病发病机制和细胞治疗未来的影响。
Prog Brain Res. 2012;200:221-41. doi: 10.1016/B978-0-444-59575-1.00010-7.
8
Transplantation of embryonic dopamine neurons for severe Parkinson's disease.胚胎多巴胺神经元移植治疗重度帕金森病
N Engl J Med. 2001 Mar 8;344(10):710-9. doi: 10.1056/NEJM200103083441002.
9
Expanded mesencephalic precursors develop into grafts of densely packed dopaminergic neurons that reinnervate the surrounding striatum and induce functional responses in the striatal neurons.扩大的中脑前体细胞发育成紧密排列的多巴胺能神经元移植物,这些移植物重新支配周围的纹状体并诱导纹状体神经元产生功能性反应。
Synapse. 2005 Oct;58(1):13-22. doi: 10.1002/syn.20179.
10
Progressive neurodegenerative and behavioural changes induced by AAV-mediated overexpression of α-synuclein in midbrain dopamine neurons.AAV 介导的α-突触核蛋白过表达诱导中脑多巴胺神经元进行性神经退行性变和行为改变。
Neurobiol Dis. 2012 Mar;45(3):939-53. doi: 10.1016/j.nbd.2011.12.013. Epub 2011 Dec 11.

引用本文的文献

1
Efficacy and efficacy-influencing factors of stem cell transplantation on patients with Parkinson's disease: a systematic review and meta-analysis.干细胞移植治疗帕金森病患者的疗效及疗效影响因素:系统评价与Meta分析
Front Neurol. 2024 Apr 12;15:1329343. doi: 10.3389/fneur.2024.1329343. eCollection 2024.
2
Dopaminergic Cell Replacement for Parkinson's Disease: Addressing the Intracranial Delivery Hurdle.帕金森病的多巴胺能细胞替代治疗:解决颅内递药难题。
J Parkinsons Dis. 2024;14(3):415-435. doi: 10.3233/JPD-230328.
3
Host-to-graft propagation of inoculated α-synuclein into transplanted human induced pluripotent stem cell-derived midbrain dopaminergic neurons.
接种的α-突触核蛋白从宿主向移植的人诱导多能干细胞衍生的中脑多巴胺能神经元的传播。
Regen Ther. 2024 Jan 6;25:229-237. doi: 10.1016/j.reth.2023.12.019. eCollection 2024 Mar.
4
Clinical results of neurorestorative cell therapies and therapeutic indications according to cellular bio-proprieties.根据细胞生物学特性的神经修复细胞疗法的临床结果及治疗适应症。
Regen Ther. 2023 Apr 13;23:52-59. doi: 10.1016/j.reth.2023.03.004. eCollection 2023 Jun.
5
The therapeutic potential of triptolide and celastrol in neurological diseases.雷公藤内酯醇和雷公藤红素在神经系统疾病中的治疗潜力。
Front Pharmacol. 2022 Oct 19;13:1024955. doi: 10.3389/fphar.2022.1024955. eCollection 2022.
6
The Roles of Gene Mutations Leading to Abnormal Aggregation of α-Synuclein in Parkinson's Disease.导致α-突触核蛋白异常聚集的基因突变在帕金森病中的作用
Front Cell Neurosci. 2022 Jul 6;16:927682. doi: 10.3389/fncel.2022.927682. eCollection 2022.
7
RT-QuIC and Related Assays for Detecting and Quantifying Prion-like Pathological Seeds of α-Synuclein.实时无偏异染 QuIC 及其相关检测方法用于检测和定量 α-突触核蛋白类朊病毒样病理种子
Biomolecules. 2022 Apr 14;12(4):576. doi: 10.3390/biom12040576.
8
The roles of connectivity and neuronal phenotype in determining the pattern of α-synuclein pathology in Parkinson's disease.连接性和神经元表型在帕金森病中α-突触核蛋白病理模式中的作用。
Neurobiol Dis. 2022 Jun 15;168:105687. doi: 10.1016/j.nbd.2022.105687. Epub 2022 Mar 10.
9
The Origins of the Protein Spread in Parkinson's Disease.帕金森病中蛋白质扩散的起源
Mov Disord Clin Pract. 2021 Aug 23;8(8):1194-1197. doi: 10.1002/mdc3.13314. eCollection 2021 Nov.
10
Neurons and Glia Interplay in α-Synucleinopathies.神经元和神经胶质细胞在α-突触核蛋白病中的相互作用。
Int J Mol Sci. 2021 May 8;22(9):4994. doi: 10.3390/ijms22094994.